Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Celcuity Inc

CELC
12,46
0,46 (3,83%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/12/202413:05GLOBECelcuity Presents Overall Survival Data from Phase 1b Study..
06/12/202422:30EDGAR2Form 8-K - Current report
06/12/202422:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/12/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/11/202422:06EDGAR2Form S-3/A - Registration statement under Securities Act of..
14/11/202423:46EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:05EDGAR2Form 8-K - Current report
14/11/202422:01GLOBECelcuity Inc. Reports Third Quarter Financial Results and..
14/11/202421:35EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202413:05GLOBECelcuity Inc. To Present at Upcoming Stifel and Jefferies..
07/11/202413:05GLOBECelcuity Inc. Schedules Release of Third Quarter 2024..
25/10/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:05EDGAR2Form 8-K - Current report
30/8/202422:46EDGAR2Form S-3 - Registration statement under Securities Act of..
28/8/202422:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/8/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
27/8/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202423:41EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
23/8/202416:27EDGAR2Form 144 - Report of proposed sale of securities
22/8/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
14/8/202423:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:10EDGAR2Form 8-K - Current report
14/8/202422:01GLOBECelcuity Inc. Reports Second Quarter Financial Results and..
07/8/202413:05GLOBECelcuity Inc. Schedules Release of Second Quarter 2024..
06/6/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202422:01GLOBECelcuity To Participate in Jefferies Global Healthcare..
31/5/202423:00EDGAR2Form 8-K - Current report
30/5/202423:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/5/202413:36GLOBECelcuity Announces Pricing of Underwritten Common Stock..
30/5/202413:05EDGAR2Form 8-K - Current report
30/5/202413:00GLOBECelcuity Inc. Announces Plan to Initiate a Phase 3 Clinical..
24/5/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202423:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:01GLOBECelcuity Inc. Reports First Quarter Financial Results and..
13/5/202423:00EDGAR2Form 8-K - Current report
08/5/202413:05GLOBECelcuity Inc. Schedules Release of First Quarter 2024..
04/4/202413:05GLOBECelcuity To Present at Upcoming Needham and Stifel Investor..
27/3/202421:01GLOBECelcuity Inc. Reports Fourth Quarter and Full Year 2023..
20/3/202412:05GLOBECelcuity Inc. Schedules Release of Fourth Quarter and Full..
06/3/202413:05GLOBECelcuity to Participate in Leerink Partners Global Biopharma..
28/2/202413:05GLOBECelcuity to Participate in Cowen’s 44th Annual Health Care..
23/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:05GLOBECelcuity Announces First Patient Dosed in Phase 1b/2..
Apertura: 11,85 Min: 11,62 Max: 12,585
Chiusura: 12,00

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network